There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

Researchers at the University of Pittsburgh have developed a nasal swab test for children and youth that helps clinicians diagnose specific asthma subtypes, or endotypes, using nasal epithelial gene ...

The new data underscore the Percepta Nasal Swab test’s ability to help physicians more accurately, quickly and confidently determine which patients with lung nodules found on computerized tomography ...

Veracyte’s latest tool for detecting lung cancer accurately divided patients with lung nodules into groups at high or low risk of having lung cancer—using only a nasal swab. The noninvasive test, ...

“We are very encouraged by these preliminary data, which suggest that our nasal swab test has the potential to transform how this disease is diagnosed, enabling lung cancer patients to get the ...

Veracyte announced it has begun rolling out its long-awaited nasal swab test for lung cancer to a limited number of clinical sites, as it continues to build up data to back its full future commercial ...

As more Americans get tested for the new coronavirus and the disease it causes, COVID-19, they’re discovering the test involves a deep nasal swab that can be uncomfortable. Called a nasopharyngeal ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc., (Nasdaq: VCYT) today announced that new data presented at the CHEST Annual Meeting 2020 show that a genomic smoking index developed for ...

Many who’ve had a nasal Covid-19 test performed on themselves have described it as feeling like that swab got as far back as their brains. If done correctly, the swab is angled parallel to the floor, ...

Data presented today at CHEST 2019 Annual Meeting; Company plans to begin making test available in early 2021 Conference call and webcast today at 5:00 p.m. ET to review third quarter 2019 Financial ...